Referências

1. Afshar-Oromieh A, 2015, EUR J NUCL MED MOL I, V42, P197, DOI 10.1007/s00259-014-2949-6
2. Bahri H, 2014, J NUCL MED, V55, P1786, DOI 10.2967/jnumed.114.144386
3. Ballas LK, 2016, J NUCL MED, V57, p6S, DOI 10.2967/jnumed.115.170142
4. Bander NH, 2005, J CLIN ONCOL, V23, P4591, DOI 10.1200/JCO.2005.05.160
5. Barbosa FG, 2020, RADIOGRAPHICS, V40, P1412, DOI 10.1148/rg.2020200058
6. Barbosa FG, 2019, RADIOGRAPHICS, V39, P186, DOI 10.1148/rg.2019180079
7. Bartolomei M, 2009, EUR J NUCL MED MOL I, V36, P1407, DOI 10.1007/s00259-009-1115-z
8. Bodei L, 2008, EUR J NUCL MED MOL I, V35, P1847, DOI 10.1007/s00259-008-0778-1
9. Brans B, 2007, EUR J NUCL MED MOL I, V34, P772, DOI 10.1007/s00259-006-0338-5
10. Calopedos RJS, 2017, PROSTATE CANCER P D, V20, P352, DOI 10.1038/pcan.2017.23
11. Carrasquillo JA, 2016, SEMIN NUCL MED, V46, P203, DOI 10.1053/j.semnuclmed.2016.01.011
12. Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z
13. Demirci E, 2018, NUCL MED COMMUN, V39, P789, DOI 10.1097/MNM.0000000000000874
14. DeNardo GL, 2012, SEMIN NUCL MED, V42, P147, DOI 10.1053/j.semnuclmed.2011.12.003
15. Drude N, 2017, METHODS, V130, P14, DOI 10.1016/j.ymeth.2017.07.004
16. Eberlein U, 2017, J NUCL MED, V58, p97S, DOI 10.2967/jnumed.116.186841
17. Eiber M, 2017, J NUCL MED
18. Eiber M, 2015, J NUCL MED, V56, P668, DOI 10.2967/jnumed.115.154153
19. Fendler WP, 2017, J NUCL MED, V58, P1196, DOI 10.2967/jnumed.117.191023
20. Fendler WP, 2017, ONCOTARGET, V8, P3581, DOI 10.18632/oncotarget.12240
21. Funkhouser J., 2002, CURR DRUG DISCOV, V2, P17
22. Gains JE, 2011, J NUCL MED, V52, P1041, DOI 10.2967/jnumed.110.085100
23. Marin JFG, 2020, RADIOGRAPHICS, V40, P1715, DOI 10.1148/rg.2020200021
24. Heinrich D, 2018, CLIN GENITOURIN CANC, V16, pE223, DOI 10.1016/j.clgc.2017.08.020
25. Hevesy G., 2014, SOURCE BOOK CHEM 190
26. Hofman MS, 2018, LANCET ONCOL, V19, P825, DOI 10.1016/S1470-2045(18)30198-0
27. Hofman MS, 2018, RADIOGRAPHICS, V38, P200, DOI 10.1148/rg.2018170108
28. Hofmann M, 2001, EUR J NUCL MED, V28, P1751, DOI 10.1007/s002590100639
29. Hope TA, 2020, J NUCL MED, V61, p255S, DOI 10.2967/jnumed.120.252122
30. Hope TA, 2018, J NUCL MED, V59, P66, DOI 10.2967/jnumed.117.202275
31. Intenzo CM, 2012, SEMIN NUCL MED, V42, P49, DOI 10.1053/j.semnuclmed.2011.07.004
32. Iten F, 2007, CLIN CANCER RES, V13, P6696, DOI 10.1158/1078-0432.CCR-07-0935
33. Iten F, 2009, CANCER-AM CANCER SOC, V115, P2052, DOI 10.1002/cncr.24272
34. Jentzen W, 2008, EUR J NUCL MED MOL I, V35, P611, DOI 10.1007/s00259-007-0554-7
35. Kircher M, 2018, ANN NUCL MED, V32, P503, DOI 10.1007/s12149-018-1290-8
36. Kong G, 2017, J CLIN ENDOCR METAB, V102, P3278, DOI 10.1210/jc.2017-00816
37. Kratochwil C, 2019, SEMIN NUCL MED, V49, P313, DOI 10.1053/j.semnuclmed.2019.02.003
38. Kratochwil C, 2016, J NUCL MED, V57, P1170, DOI 10.2967/jnumed.115.171397
39. KRENNING EP, 1989, LANCET, V1, P242
40. Kumar C, 2016, INT J RADIAT BIOL, V92, P173, DOI 10.3109/09553002.2016.1144944
41. Kwekkeboom DJ, 2008, J CLIN ONCOL, P2124, DOI [10.1016/B978-1-4557-2865-7.00105-3, DOI 10.1016/B978-1-4557-2865-7.00105-3]
42. Michalski K, 2021, EUR J NUCL MED MOL I, V48, P2024, DOI 10.1007/s00259-020-05160-8
43. Murthy R, 2005, RADIOGRAPHICS, V25, pS41, DOI 10.1148/rg.25si055515
44. Oberg K, 2012, ANN ONCOL, V23, P124, DOI 10.1093/annonc/mds295
45. Parisi MT, 2016, SEMIN NUCL MED, V46, P184, DOI 10.1053/j.semnuclmed.2016.02.002
46. Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755
47. Perez PM, 2019, CLIN NUCL MED, V44, pE28, DOI 10.1097/RLU.0000000000002367
48. Rahbar K, 2017, J NUCL MED, V58, P85, DOI 10.2967/jnumed.116.183194
49. Rahbar K, 2016, CLIN NUCL MED, V41, P522, DOI 10.1097/RLU.0000000000001240
50. Rauscher I, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0072-6
51. Rizzini EL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63302-2
52. Sangro B, 2012, J HEPATOL, V56, P464, DOI 10.1016/j.jhep.2011.07.012
53. Sansovini M, 2017, EUR J NUCL MED MOL I, V44, P490, DOI 10.1007/s00259-016-3533-z
54. Sapienza MT, 2019, CLINICS, V74, DOI 10.6061/clinics/2019/e835
55. Schoder H, 2016, J CLIN ONCOL, V34, P3591, DOI 10.1200/JCO.2016.69.3747
56. Sgouros G, 2004, J NUCL MED, V45, P1366
57. Shah MH, 2018, J NATL COMPR CANC NE, V16, P693, DOI 10.6004/jnccn.2018.0056
58. Sharma P, 2021, CLIN NUCL MED, V46, pe141, DOI 10.1097/RLU.0000000000003489
59. Silberstein EB, 2012, J NUCL MED, V53, P1633, DOI 10.2967/jnumed.112.105148
60. Sisson JC, 2012, SEMIN NUCL MED, V42, P171, DOI 10.1053/j.semnuclmed.2011.11.004
61. Strosberg J, 2017, NEW ENGL J MED, V376, P125, DOI 10.1056/NEJMoa1607427
62. Strosberg J, 2018, J CLIN ONCOL, V36, P2578, DOI 10.1200/JCO.2018.78.5865
63. Suman S, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20190380
64. Taieb D, 2019, ENDOCR-RELAT CANCER, V26, pR627, DOI 10.1530/ERC-19-0165
65. Turner JH, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20180440
66. Turner JH, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170893
67. Valent P, 2016, J INNATE IMMUN, V8, P111, DOI 10.1159/000443526
68. van Dyck CH, 2018, BIOL PSYCHIAT, V83, P311, DOI 10.1016/j.biopsych.2017.08.010
69. Violet J, 2019, J NUCL MED, V60, P517, DOI 10.2967/jnumed.118.219352
70. Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307
71. Walenkamp AME, 2017, J NUCL MED, V58, p77S, DOI 10.2967/jnumed.116.186874
72. Watabe T, 2020, J NUCL MED, V61, P563, DOI 10.2967/jnumed.119.233122
73. Winther-Larsen A, 2016, LUNG CANCER, V94, P81, DOI 10.1016/j.lungcan.2016.01.024
74. Yordanova A, 2017, ONCOTARGETS THER, V10, P4821, DOI 10.2147/OTT.S140671